American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
By D. Saslow, C. Runowicz, D. Solomon, A. Moscicki, Robert A. Smith, H. Eyre, C. Cohen. Ca, 2002
893 citations recorded by the source corpus.
An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented. The new screening recommendations address when to begin screening, when screening may be discontinued, whether to screen women who have had a hysterectomy, appropriate screening intervals, and new screening technologies, including liquid‐based cytology and HPV DNA testing.
Subfields: Epidemiology, Obstetrics and Gynecology, Oncology
View Paper: https://www.semanticscholar.org/paper/4eca7c8ff5961ed9981bbc0fe4ee5f396e39f30d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Schiller
- I. Evers
- D. Solomon
- T. Wright
- A. Rodriguez
- L. Massad
- H. D. de Valk
- C. Dunton
Citations in the corpus
- Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study (2004, neutral): “Current is defined by the standard of most US professional organizations: a Pap smear performed within the past 3 years.(15,16) For women who reported having had a Pap smear but did not respond to the question about the timing of the most recent test, we assumed that they did not have a current Pap ”
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. (2007, background): “Therefore, HPV testing should be used only for routine screening in women 30 years of age and older.(3,66) A number of large studies have evaluated screening using a combination of HPV testing and cervical cytology (either liquid-based or conventional cytology).”
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. (2012, neutral): “The American Cancer Society (ACS) guideline for the early detection of cervical cancer was last reviewed and updated in 2002; for the first time, those recommendations incorporated human papillomavirus (HPV) DNA testing.(1) Since that time, numerous studies have been published that support changes t”
- Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands (2004, background): “The decline in Pap smear use with advancing age is more understandable because most guidelines recommend that even healthy women can stop Pap smears at age 65 or 70 years if they have had normal results 3 or more times (21, 22, 33).”
- Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. (2007, background): “Understanding whether vaccination provides any therapeutic benefit to infected women is of importance in countries where HPV DNA testing has been incorporated into cervical cancer screening programs.(18,19) Women in such programs who test positive for HPV might want to avail themselves of the vaccin”
- A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a (2013, neutral): “poned when a woman is menstruating [170, 172, 173].”